Close



Feb 27, 2024 04:11PM
Feb 27, 2024 04:08PM
Feb 7, 2023 07:00AM
Nov 1, 2022 07:00AM
Aug 2, 2022 07:00AM
May 5, 2022 08:15AM
May 3, 2022 01:25PM Incyte (INCY) PT Raised to $77 at Stifel
May 3, 2022 07:00AM
Mar 26, 2022 10:40AM
Mar 14, 2022 08:02AM
Mar 14, 2022 08:00AM
Feb 8, 2022 07:00AM
Dec 14, 2021 04:31PM
Dec 14, 2021 04:30PM Incyte Announces Acceptance and Priority Review of sNDA for Ruxolitinib Cream (Opzelura™) as a Treatment for Patients with Vitiligo
Nov 2, 2021 07:00AM
Nov 1, 2021 07:03AM
Nov 1, 2021 07:00AM
Sep 1, 2021 12:36PM
Aug 3, 2021 07:00AM
Jul 16, 2021 10:01AM
Jul 16, 2021 10:00AM Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
Jul 14, 2021 05:02PM
Jul 14, 2021 05:00PM
Jun 24, 2021 03:30PM
Jun 24, 2021 03:30PM
Jun 22, 2021 12:38PM
Jun 11, 2021 10:23AM
Jun 11, 2021 07:30AM Incyte (INCY) Announces U.S. FDA Has Extended NDA Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis
Jun 11, 2021 07:30AM
Jun 8, 2021 07:32AM
Jun 8, 2021 07:30AM
May 4, 2021 07:00AM
Apr 6, 2021 04:30PM
Apr 6, 2021 04:30PM
Mar 9, 2021 07:48AM BofA Would Buy These 4 SMid Cap Biotechs on the Pullback
Feb 22, 2021 08:06AM
Feb 22, 2021 08:00AM
Feb 19, 2021 08:02AM
Feb 19, 2021 08:00AM
Jan 21, 2021 04:33PM
Jan 21, 2021 04:30PM
Dec 29, 2020 07:42AM Merck (MRK) Included in Mizuho's List of Top Oncology Picks for 2021
May 5, 2020 07:00AM
Apr 21, 2020 07:07AM
Mar 3, 2020 04:30PM
Feb 19, 2020 08:22AM
Feb 13, 2020 07:00AM
Nov 27, 2019 07:30AM
Nov 27, 2019 07:30AM Incyte Announces Acceptance and Priority Review of NDA for Pemigatinib as a Treatment for Patients with Cholangiocarcinoma
Apr 30, 2019 07:00AM

12,339 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All